Study design considerations in clinical outcome research of lung cancer using microarray analysis
- 1 November 2004
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 46 (2) , 215-226
- https://doi.org/10.1016/j.lungcan.2004.03.012
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- p53 Mutations and Survival in Stage I Non-Small-Cell Lung Cancer: Results of a Prospective StudyJNCI Journal of the National Cancer Institute, 2003
- Cluster analysisPublished by Taylor & Francis ,2003
- cDNA microarray analysis of gene expression in pathologic stage IA nonsmall cell lung carcinomasCancer, 2003
- Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugsOncogene, 2003
- Summaries of Affymetrix GeneChip probe level dataNucleic Acids Research, 2003
- Identifying differentially expressed genes using false discovery rate controlling proceduresBioinformatics, 2003
- Gene-expression profiles predict survival of patients with lung adenocarcinomaNature Medicine, 2002
- Design of studies using DNA microarraysGenetic Epidemiology, 2002
- Diversity of gene expression in adenocarcinoma of the lungProceedings of the National Academy of Sciences, 2001
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences, 2001